Wednesday 24/November/2021 08:44 AM
Covaxin 50% effective against symptomatic COVID: Lancet study
New Delhi: Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world...









